Hongcheng Zhu

7PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingPredictive and prognostic markersSocio-economic development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 26, 2025
PD-1 inhibitor improves radiosensitivity by tumor vessel normalization.

Shengnan Hao, Dashan Ai, Quanxin Wang

|Mar 07, 2025
Radiation Dose-Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy.

Ihsuan Tseng, Yun Chen, Dashan Ai

|Oct 09, 2023
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation.

Zhuocheng Xin, Qi Liu, Dashan Ai

|Mar 14, 2023
Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020.

Hongcheng Zhu, Zezhou Wang, Bingbin Deng

|Feb 15, 2023
Comparison of treatment strategies for resectable locally advanced primary mucinous adenocarcinoma of the lung.

Yu Gu, Hongcheng Zhu, Jiaying Deng

|Sep 24, 2022
Esophageal cancer in China: Practice and research in the new era.

Hongcheng Zhu, Xiao Ma, Ting Ye

Pageof 2

Frequent Collaborators

2 joint publications

Dashan Ai

2 joint publications

Kuaile Zhao

1 joint publications

Melinda Mushonga

1 joint publications

Mary Gospodarowicz